These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1907003

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Imipramine prevents gastric lesions induced by centrally administered thyrotropin-releasing hormone (TRH) in rats.
    Hernandez DE, Arredondo ME, Xue BG.
    Neurosci Lett; 1990 Apr 06; 111(3):339-43. PubMed ID: 2159606
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vagus-mediated activation of mucosal mast cells in the stomach: effect of ketotifen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue.
    Király A, Süto G, Tam B, Hermann V, Mózsik G.
    J Physiol Paris; 2000 Apr 06; 94(2):131-4. PubMed ID: 10791694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanisms.
    Taché Y, Yoneda M, Kato K, Király A, Sütö G, Kaneko H.
    J Gastroenterol Hepatol; 1994 Apr 06; 9 Suppl 1():S29-35. PubMed ID: 7881015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
    Cardin S, Soll AH, Taché Y.
    J Pharmacol Exp Ther; 1995 Nov 06; 275(2):667-73. PubMed ID: 7473153
    [Abstract] [Full Text] [Related]

  • 10. Gastric antisecretory and antiulcer actions of interleukin-1. Evidence for the presence of an "immune-brain-gut" axis.
    Uehara A, Okumura T, Kitamori S, Shibata Y, Harada K, Okamura K, Takasugi Y, Namiki M.
    J Clin Gastroenterol; 1992 Nov 06; 14 Suppl 1():S149-55. PubMed ID: 1629572
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Central nervous system action of thyrotropin-releasing hormone to increase gastric mucosal blood flow in the rat.
    Thiefin G, Taché Y, Leung FW, Guth PH.
    Gastroenterology; 1989 Aug 06; 97(2):405-11. PubMed ID: 2501141
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
    Joh T, Oshima T, Takahashi N, Kaneko H, Sasaki M, Kataoka H, Watanabe K, Sobue M, Suzuki H, Nomura T, Ohara H, Itoh M.
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb 06; 288(2):G230-4. PubMed ID: 15499083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Central nervous system action of calcitonin to alter experimental gastric ulcers in rats.
    Taché Y, Kolve E, Maeda-Hagiwara M, Kauffman GL.
    Gastroenterology; 1988 Jan 06; 94(1):145-50. PubMed ID: 3335286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Central action of TRH to induce vagally mediated gastric cytoprotection and ulcer formation in rats.
    Taché Y, Yoneda M.
    J Clin Gastroenterol; 1993 Jan 06; 17 Suppl 1():S58-63. PubMed ID: 8283016
    [Abstract] [Full Text] [Related]

  • 19. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways.
    Yang H, Kawakubo K, Taché Y.
    Am J Physiol; 1999 Sep 06; 277(3):G555-62. PubMed ID: 10484380
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.